$336 Million is the total value of DAFNA Capital Management LLC's 74 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 32.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STXS | STEREOTAXIS INC | $69,634,000 | +42.2% | 13,680,554 | 0.0% | 20.72% | +30.2% | |
| FATE | Sell | FATE THERAPEUTICS INC | $30,403,000 | +73.5% | 334,360 | -23.7% | 9.05% | +58.8% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $23,205,000 | +7.4% | 206,911 | -11.2% | 6.90% | -1.7% |
| SAGE | Buy | SAGE THERAPEUTICS INC | $15,685,000 | +62.1% | 181,306 | +14.5% | 4.67% | +48.4% |
| DRNA | Buy | DICERNA PHARMACEUTICALS INC | $12,948,000 | +58.4% | 587,756 | +29.4% | 3.85% | +45.1% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $8,838,000 | +1.9% | 92,208 | +2.2% | 2.63% | -6.7% |
| GLPG | Buy | GALAPAGOS NVspon adr | $7,956,000 | +26.3% | 80,375 | +81.1% | 2.37% | +15.6% |
| DXCM | DEXCOM INC | $7,815,000 | -10.3% | 21,138 | 0.0% | 2.32% | -17.9% | |
| ATRC | ATRICURE INC | $7,417,000 | +39.5% | 133,229 | 0.0% | 2.21% | +27.7% | |
| IBB | Sell | ISHARES TR NASDAQ BIOTECHetf | $7,181,000 | -5.1% | 47,400 | -15.2% | 2.14% | -13.1% |
| BHVN | Sell | BIOHAVEN PHARMACEUTICALS HOLD | $7,037,000 | +27.9% | 82,100 | -3.0% | 2.09% | +17.1% |
| CSII | CARDIOVASCULAR SYSTEMS INC | $6,617,000 | +11.2% | 151,200 | 0.0% | 1.97% | +1.8% | |
| ARNA | Buy | ARENA PHARMACEUTICALS INC | $5,902,000 | +4.1% | 76,815 | +1.3% | 1.76% | -4.7% |
| XENE | XENON PHARMACEUTICALS INC | $5,330,000 | +38.9% | 346,535 | 0.0% | 1.59% | +27.2% | |
| PRQR | PROQR THERAPEUTICS N V | $5,197,000 | -12.3% | 1,237,400 | 0.0% | 1.55% | -19.8% | |
| AFMD | Sell | AFFIMED NV | $5,089,000 | +62.4% | 874,357 | -5.4% | 1.51% | +48.7% |
| STIM | Sell | NEURONETICS INC | $4,930,000 | +104.6% | 443,717 | -10.5% | 1.47% | +87.4% |
| IDYA | IDEAYA BIOSCIENCES INC | $4,643,000 | +11.4% | 331,661 | 0.0% | 1.38% | +2.1% | |
| TBIO | Buy | TRANSLATE BIO INC | $4,154,000 | +59.8% | 225,393 | +18.1% | 1.24% | +46.3% |
| ARAY | Sell | ACCURAY INC | $4,063,000 | +57.6% | 974,400 | -9.3% | 1.21% | +44.3% |
| CARA | Buy | CARA THERAPEUTICS INC | $3,956,000 | +25.7% | 261,442 | +5.7% | 1.18% | +15.1% |
| AERI | Buy | AERIE PHARMACEUTICALS INC | $3,897,000 | +16.4% | 288,440 | +1.4% | 1.16% | +6.6% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $3,875,000 | -14.1% | 23,237 | -20.5% | 1.15% | -21.4% |
| AGTC | Sell | APPLIED GENETIC TECHNOL CORP | $3,695,000 | -30.6% | 903,429 | -17.5% | 1.10% | -36.5% |
| RADIUS HEALTH INCnote 3.000% 9/0 | $3,586,000 | +8.2% | 4,000,000 | 0.0% | 1.07% | -1.0% | ||
| LMNX | LUMINEX CORP | $3,563,000 | -11.9% | 154,091 | 0.0% | 1.06% | -19.4% | |
| SAVA | New | CASSAVA SCIENCES INC | $3,069,000 | – | 450,000 | +100.0% | 0.91% | – |
| CNST | Sell | CONSTELLATION PHARMACEUTICAL | $2,897,000 | -21.0% | 100,594 | -44.4% | 0.86% | -27.7% |
| HOOK | Buy | HOOKIPA PHARMA INC | $2,773,000 | +1226.8% | 250,000 | +1033.2% | 0.82% | +1113.2% |
| KNTE | New | KINNATE BIOPHARMA INC | $2,710,000 | – | 68,121 | +100.0% | 0.81% | – |
| VERO | New | VENUS CONCEPT INC | $2,595,000 | – | 1,500,000 | +100.0% | 0.77% | – |
| ETNB | Sell | 89BIO INC | $2,570,000 | -9.3% | 105,478 | -4.5% | 0.76% | -17.0% |
| VKTX | Buy | VIKING THERAPEUTICS INC | $2,567,000 | -2.2% | 455,900 | +1.1% | 0.76% | -10.4% |
| OTIC | Sell | OTONOMY INC | $2,521,000 | -9.7% | 389,592 | -43.5% | 0.75% | -17.3% |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $2,512,000 | +177.0% | 43,916 | +46.1% | 0.75% | +153.2% |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $2,392,000 | +358.2% | 668,148 | +235.0% | 0.71% | +318.8% |
| MORF | New | MORPHIC HOLDING INC | $2,062,000 | – | 61,467 | +100.0% | 0.61% | – |
| KDMN | Sell | KADMON HOLDINGS INC | $1,952,000 | -11.6% | 470,361 | -16.5% | 0.58% | -19.1% |
| ALEC | Sell | ALECTOR INC | $1,929,000 | +30.8% | 127,500 | -8.9% | 0.57% | +19.8% |
| STRO | Sell | SUTRO BIOPHARMA INC | $1,845,000 | +54.4% | 85,000 | -28.5% | 0.55% | +41.5% |
| MEIP | Buy | MEI PHARMA INC | $1,824,000 | -12.2% | 691,000 | +3.8% | 0.54% | -19.6% |
| PRVL | PREVAIL THERAPEUTICS INC | $1,730,000 | +126.4% | 75,000 | 0.0% | 0.52% | +107.7% | |
| NTUS | Buy | NATUS MEDICAL INC | $1,715,000 | +133.3% | 85,575 | +99.5% | 0.51% | +113.4% |
| LQDA | LIQUIDIA TECHNOLOGIES INC | $1,696,000 | -40.0% | 575,000 | 0.0% | 0.50% | -45.1% | |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $1,693,000 | +137.1% | 16,668 | +80.6% | 0.50% | +117.2% |
| FSDC | New | FS DEVELOPMENT CORP | $1,650,000 | – | 150,000 | +100.0% | 0.49% | – |
| SCYX | New | SCYNEXIS INC | $1,530,000 | – | 200,000 | +100.0% | 0.46% | – |
| JNJ | JOHNSON AND JOHNSON | $1,479,000 | +5.7% | 9,400 | 0.0% | 0.44% | -3.3% | |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $1,426,000 | +9.4% | 113,202 | -23.6% | 0.42% | 0.0% |
| HARP | HARPOON THERAPEUTICS INC | $1,414,000 | -2.2% | 85,119 | 0.0% | 0.42% | -10.4% | |
| CGEN | COMPUGEN LTDord | $1,395,000 | -25.5% | 115,202 | 0.0% | 0.42% | -31.9% | |
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $1,376,000 | +14.1% | 1,500,000 | 0.0% | 0.41% | +4.3% | ||
| BLUE | BLUEBIRD BIO INC | $1,310,000 | -19.8% | 30,273 | 0.0% | 0.39% | -26.6% | |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $1,311,000 | -53.9% | 49,263 | -67.8% | 0.39% | -57.8% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $1,288,000 | +4.2% | 49,600 | -31.2% | 0.38% | -4.7% |
| VRNA | VERONA PHARMA PLCsponsored ads | $1,131,000 | +12.2% | 161,507 | 0.0% | 0.34% | +2.7% | |
| ACET | Buy | ADICET BIO INC | $1,090,000 | +35.7% | 77,577 | +14.8% | 0.32% | +24.1% |
| PHAS | PHASEBIO PHARMACEUTICALS INC | $1,077,000 | -4.3% | 320,542 | 0.0% | 0.32% | -12.6% | |
| LRMR | Sell | LARIMAR THERAPEUTICS INC | $1,037,000 | -13.7% | 48,428 | -38.8% | 0.31% | -20.8% |
| RVMD | New | REVOLUTION MEDICINES INC | $891,000 | – | 22,500 | +100.0% | 0.26% | – |
| PAND | New | PANDION THERAPEUTICS INC | $865,000 | – | 58,222 | +100.0% | 0.26% | – |
| MASI | MASIMO CORPORATION | $805,000 | +13.7% | 3,000 | 0.0% | 0.24% | +4.3% | |
| MDGL | MADRIGAL PHARMACEUTICALS INC | $734,000 | -6.4% | 6,600 | 0.0% | 0.22% | -14.5% | |
| NXTC | Sell | NEXTCURE INC | $709,000 | -5.2% | 65,000 | -23.5% | 0.21% | -13.2% |
| INGN | INOGEN INC | $670,000 | +54.0% | 15,000 | 0.0% | 0.20% | +41.1% | |
| ATHA | New | ATHIRA PHARMA INC | $566,000 | – | 16,531 | +100.0% | 0.17% | – |
| GNFT | New | GENFIT S Aads | $549,000 | – | 114,341 | +100.0% | 0.16% | – |
| ISEE | Sell | IVERIC BIO INC | $476,000 | -73.8% | 68,951 | -78.6% | 0.14% | -76.0% |
| RDUS | RADIUS HEALTH INC | $393,000 | +57.8% | 22,000 | 0.0% | 0.12% | +44.4% | |
| BEAT | Sell | BIOTELEMETRY INC | $375,000 | -86.4% | 5,200 | -91.4% | 0.11% | -87.5% |
| KURA | Sell | KURA ONCOLOGY INC | $294,000 | -75.4% | 9,000 | -76.9% | 0.09% | -77.6% |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $222,000 | -85.4% | 10,000 | -90.3% | 0.07% | -86.6% |
| SCPH | Sell | SCPHARMACEUTICALS INC | $206,000 | -69.6% | 38,891 | -57.2% | 0.06% | -72.3% |
| LCTX | Sell | LINEAGE CELL THERAPEUTICS INC | $141,000 | +58.4% | 80,000 | -15.8% | 0.04% | +44.8% |
| CRDF | Exit | CARDIFF ONCOLOGY INC | $0 | – | -5,000 | -100.0% | -0.02% | – |
| ASLN | Exit | ASLAN PHARMACEUTICALS LTDads | $0 | – | -86,082 | -100.0% | -0.05% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -9,950 | -100.0% | -0.15% | – |
| GMDA | Exit | GAMIDA CELL LTD | $0 | – | -140,000 | -100.0% | -0.19% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -35,573 | -100.0% | -0.19% | – |
| CHMA | Exit | CHIASMA INC | $0 | – | -153,208 | -100.0% | -0.21% | – |
| DMAC | Exit | DIAMEDICA THERAPEUTICS INC | $0 | – | -156,529 | -100.0% | -0.22% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -144,650 | -100.0% | -0.25% | – |
| AXGT | Exit | AXOVANT SCIENCES LTD | $0 | – | -171,083 | -100.0% | -0.26% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | -341,779 | -100.0% | -0.28% | – |
| SPRO | Exit | SPERO THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.36% | – |
| SPPI | Exit | SPECTRUM PHARMACEUTICALS INC | $0 | – | -514,891 | -100.0% | -0.68% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -749,051 | -100.0% | -0.84% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -208,054 | -100.0% | -0.85% | – |
| ARCT | Exit | ARCTURUS THERAPEUTICS HLDG I | $0 | – | -229,652 | -100.0% | -3.20% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -260,905 | -100.0% | -7.21% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.